Evista (raloxifene) can help prevent breast cancer in postmenopausal women with osteoporosis

February 2005

There's more evidence that Evista (raloxifene) can help prevent breast cancer in postmenopausal women with osteoporosis.

Evista is approved only to prevent or treat osteoporosis in postmenopausal women. But these women seem to have a 60% reduction in breast cancer while taking Evista.

But don't recommend Evista just to prevent breast cancer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote